Detalhe da pesquisa
1.
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Proc Natl Acad Sci U S A
; 115(50): E11671-E11680, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30487219
2.
NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells.
Cell Rep Med
; 2(5): 100279, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34095881
3.
Determination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 microl) blood samples.
Cancer Chemother Pharmacol
; 61(6): 1027-35, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17668210
4.
SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.
Cancer Res
; 65(12): 5358-64, 2005 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15958584
5.
Tumoricidal effect of calicheamicin immuno-conjugates using a passive targeting strategy.
Int J Oncol
; 28(3): 675-84, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16465373
6.
Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts.
Clin Cancer Res
; 10(13): 4538-49, 2004 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15240546
7.
Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells.
Cancer Res
; 71(12): 4236-46, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21540235
8.
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies.
Blood
; 103(5): 1807-14, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14615373